We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Bone-Targeted Therapy in Early Breast Cancer.
- Authors
Jerzak, Katarzyna J.; Raphael, Jacques; Desautels, Danielle N.; Blanchette, Phillip S.; Tyono, Ivan; Pritchard, Kathleen I.
- Abstract
Aromatase inhibitors (AIs) play an important role in the adjuvant treatment of hormone receptor--positive breast cancer, but they are associated with bone loss and increased fracture risk. Although several guidelines for the management of osteoporosis and osteopenia exist, their algorithms do not account for the use of AIs. In this article, we describe the role of bone-targeted therapies, specifically for managing early breast cancer, by reviewing their bone-specific and cancer-specific benefits.
- Subjects
BREAST tumor treatment; AROMATASE inhibitors; BONE fractures; BONES; COMBINED modality therapy; DRUG delivery systems; OSTEOPENIA; OSTEOPOROSIS; INJURY risk factors; THERAPEUTICS
- Publication
Oncology (08909091), 2018, Vol 32, Issue 11, p562
- ISSN
0890-9091
- Publication type
Article